BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 10835700)

  • 1. [Thrombotic microangiopathies: HUS/TTP. Physiopathological aspects].
    Sánchez Avalos JC
    Medicina (B Aires); 2000; 60(1):46-58. PubMed ID: 10835700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
    Byrnes JJ; Moake JL
    Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology and treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS).
    Kakishita E
    Int J Hematol; 2000 Jun; 71(4):320-7. PubMed ID: 10905050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma von Willebrand Factor Antigen (vWF:AG) and thrombomodulin (TM) levels in Adult Thrombotic Thrombocytopenic Purpura/Hemolytic Uremic Syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).
    Zeigler ZR; Rosenfeld CS; Andrews DF; Nemunaitis J; Raymond JM; Shadduck RK; Kramer RE; Gryn JF; Rintels PB; Besa EC; George JN
    Am J Hematol; 1996 Dec; 53(4):213-20. PubMed ID: 8948657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemolytic uremic syndrome (HUS): pathophysiology--with reference to the differentiation between HUS and thrombotic thrombocytopenic purpura].
    Naruse T
    Nihon Rinsho; 1993 Jan; 51(1):187-92. PubMed ID: 8433517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review.
    Bosch T; Wendler T
    Ther Apher; 2001 Jun; 5(3):182-5. PubMed ID: 11467754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiology of thrombotic microangiopathies: current understanding].
    Coppo P; Veyradier A; Durey MA; Fremeaux-Bacchi V; Scrobohaci ML; Amesland F; Bussel A
    Ann Med Interne (Paris); 2002 May; 153(3):153-66. PubMed ID: 12218898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology and management of thrombotic microangiopathies.
    Ruggenenti P; Remuzzi G
    J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic thrombocytopenic purpura--a syndrome caused by multiple pathogenetic mechanisms.
    Lian EC
    Invest Clin; 2001 May; 42 Suppl 1():75-86. PubMed ID: 11416985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic microangiopathy: differential diagnosis, pathophysiology and therapeutic strategies.
    Mayer SA; Aledort LM
    Mt Sinai J Med; 2005 May; 72(3):166-75. PubMed ID: 15915311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of transforming growth factor beta1 in microvascular endothelial cell apoptosis associated with thrombotic thrombocytopenic purpura and hemolytic-uremic syndrome.
    Mauro M; Kim J; Costello C; Laurence J
    Am J Hematol; 2001 Jan; 66(1):12-22. PubMed ID: 11426486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Moake JL; McPherson PD
    Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic thrombocytopenic purpura and related disorders.
    Ruggenenti P; Remuzzi G
    Hematol Oncol Clin North Am; 1990 Feb; 4(1):219-41. PubMed ID: 2107174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet activation in hemolytic uremic syndrome.
    Karpman D; Manea M; Vaziri-Sani F; Ståhl AL; Kristoffersson AC
    Semin Thromb Hemost; 2006 Mar; 32(2):128-45. PubMed ID: 16575688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: pathophysiology and management.
    Myers L
    Nephrol Nurs J; 2002 Apr; 29(2):171-80; quiz 181-2. PubMed ID: 11997952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies.
    Moake J
    Best Pract Res Clin Haematol; 2009 Dec; 22(4):567-76. PubMed ID: 19959109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the pathogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Franchini M; Zaffanello M; Veneri D
    Thromb Res; 2006; 118(2):177-84. PubMed ID: 16126255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis on thrombotic thrombocytopenic purpura and hemolytic uremic syndrome, with plasma level of cytokine].
    Wada H; Saitoh M; Tamaki S; Masuya M; Morita K; Tabata M; Tanigawa M; Kageyama S; Tsuzi K; Ohta C
    Rinsho Ketsueki; 1990 Sep; 31(9):1537-43. PubMed ID: 2246829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.